References
1. Javad H, Al-Yarubi S, Chacko AP, Sankhla D, Al-Futasi A, Abdelmogheth AA, et al. Semilobar Holoprosencephaly with Neurogenic Hypernatraemia: Two new cases. Sultan Qaboos University medical journal. 2013;13(3):E463-6.
2. Golden JA. Towards a greater understanding of the pathogenesis of holoprosencephaly. Brain & development. 1999;21(8):513-21.
3. Hasegawa Y, Hasegawa T, Yokoyama T, Kotoh S, Tsuchiya Y. Holoprosencephaly associated with diabetes insipidus and syndrome of inappropriate secretion of antidiuretic hormone. The Journal of pediatrics. 1990;117(5):756-8.
4. Savasta S, Chiapedi S, Borali E, Perrini S, Sepe V, Caimmi S, et al. Holoprosencephaly with neurogenic hypernatremia: a new case. Child’s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2008;24(1):139-42.
5. Kourti M, Pavlou E, Rousso I, Economou I, Athanassiadou F. Holoprosencephaly and diabetes insipidus in a 3-month-old infant. Journal of child neurology. 2008;23(1):118-20.
6. Di Iorgi N, Napoli F, Allegri AEM, Olivieri I, Bertelli E, Gallizia A, et al. Diabetes insipidus–diagnosis and management. Hormone research in paediatrics. 2012;77(2):69-84.
7. BRAVERMAN LE, MANCINI JP, MCGOLDRICK DM. Hereditary idiopathic diabetes insipidus: a case report with autopsy findings. Annals of Internal Medicine. 1965;63(3):503-8.
8. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, et al. Central diabetes insipidus in children and young adults. New England Journal of Medicine. 2000;343(14):998-1007.
9. Dhamija R, Babovic-Vuksanovic D. FGFR1-Related Hartsfield Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, et al., editors. GeneReviews(®). Seattle (WA): University of Washington, Seattle
Copyright © 1993-2022, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993.
10. Tasdemir S, Sahin I, Cayır A, Doneray H, Solomon BD, Muenke M, et al. Holoprosencephaly: ZIC2 mutation in a case with panhypopituitarism. Journal of Pediatric Endocrinology and Metabolism. 2014;27(7-8):777-81.
11. Olsen CL, Hughes JP, Youngblood LG, Sharpe‐Stimac M. Epidemiology of holoprosencephaly and phenotypic characteristics of affected children: New York State, 1984–1989. American journal of medical genetics. 1997;73(2):217-26.
12. Plawner L, Delgado M, Miller V, Levey E, Kinsman S, Barkovich A, et al. Neuroanatomy of holoprosencephaly as predictor of function: beyond the face predicting the brain. Neurology. 2002;59(7):1058-66.
13. Hahn JS, Hahn SM, Kammann Η, Barkovich AJ, Clegg NJ, Delgado MR, et al. Endocrine disorders associated with holoprosencephaly. Journal of Pediatric Endocrinology and Metabolism. 2005;18(10):935-42.
14. Javad H, Al-Yarubi S, Chacko AP, Sankhla D, Al-Futasi A, Abdelmogheth AA, et al. Semilobar holoprosencephaly with neurogenic hypernatraemia: two new cases. Sultan Qaboos University Medical Journal. 2013;13(3):E463.
15. Tekendo‐Ngongang C, Owosela B, Muenke M, Kruszka P, editors. Comorbidity of congenital heart defects and holoprosencephaly is likely genetically driven and gene‐specific. American Journal of Medical Genetics Part C: Seminars in Medical Genetics; 2020: Wiley Online Library.
16. Demir N, Doğan M, Peker E, Bulan K, Tuncer O. A very rare entity of diabetes insipidus associated with Edwards syndrome. Genetics research. 2013;95(4):130-2.
17. Sng A, Loke K, Lim Y. A case of neonatal central diabetes insipidus in a premature infant: challenges in diagnosis and management. Case Rep J. 2018;2(2):010.
18. Fenske W, Allolio B. Current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. The Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3426-37.
19. Sethi RV, Marino R, Niemierko A, Tarbell NJ, Yock TI, MacDonald SM. Delayed diagnosis in children with intracranial germ cell tumors. The Journal of pediatrics. 2013;163(5):1448-53.
20. Gregoire JR. Adjustment of the osmostat in primary aldosteronism. Mayo Clinic proceedings. 1994;69(11):1108-10.
21. DeRubertis FR, Michelis MF, Davis BB. ”Essential” Hypernatremia: Report of Three Cases and Review of the Literature. Archives of Internal Medicine. 1974;134(5):889-95.
22. Godano E, Morana G, Di Iorgi N, Pistorio A, Allegri AEM, Napoli F, et al. Role of MRI T2-DRIVE in the assessment of pituitary stalk abnormalities without gadolinium in pituitary diseases. European journal of endocrinology. 2018;178(6):613-22.
23. Dabrowski E, Kadakia R, Zimmerman D. Diabetes insipidus in infants and children. Best Practice & Research Clinical Endocrinology & Metabolism. 2016;30(2):317-28.
24. Garrahy A, Thompson CJ. Management of central diabetes insipidus. Best Practice & Research Clinical Endocrinology & Metabolism. 2020;34(5):101385.
25. Raisingani M, Palliyil Gopi R, Shah B. Use of chlorothiazide in the management of central diabetes insipidus in early infancy. Case reports in pediatrics. 2017;2017.
26. Moritz ML, Ayus JC. Disorders of water metabolism in children. Pediatrics in review. 2002;23(11):371.
27. Abraham MB, Rao S, Price G, Choong CS. Efficacy of hydrochlorothiazide and low renal solute feed in neonatal central diabetes insipidus with transition to oral desmopressin in early infancy. International journal of pediatric endocrinology. 2014;2014(1):1-6.
28. Saifan C, Nasr R, Mehta S, Sharma Acharya P, Perrera I, Faddoul G, et al. Diabetes insipidus: a challenging diagnosis with new drug therapies. International Scholarly Research Notices. 2013;2013.
29. Van der Kaay DC, Van Heel WJ, Dudink J, van den Akker EL. Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing. Journal of Pediatric Endocrinology and Metabolism. 2014;27(7-8):769-71.